R0V Stock Overview
Provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Revenio Group Oyj Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €31.84 |
| 52 Week High | €33.32 |
| 52 Week Low | €31.36 |
| Beta | 1.45 |
| 11 Month Change | 0% |
| 3 Month Change | -0.13% |
| 1 Year Change | n/a |
| 33 Year Change | -7.84% |
| 5 Year Change | n/a |
| Change since IPO | 106.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| R0V | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.4% | -0.4% |
| 1Y | n/a | -7.1% | 7.1% |
Return vs Industry: Insufficient data to determine how R0V performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how R0V performed against the German Market.
Price Volatility
| R0V volatility | |
|---|---|
| R0V Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: R0V has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine R0V's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 217 | Jouni Toijala | www.reveniogroup.fi |
Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging and DRSplus, a device for detection of diabetic retinopathy; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images.
Revenio Group Oyj Fundamentals Summary
| R0V fundamental statistics | |
|---|---|
| Market cap | €607.38m |
| Earnings (TTM) | €19.15m |
| Revenue (TTM) | €98.03m |
31.7x
P/E Ratio6.2x
P/S RatioIs R0V overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| R0V income statement (TTM) | |
|---|---|
| Revenue | €98.03m |
| Cost of Revenue | €28.01m |
| Gross Profit | €70.02m |
| Other Expenses | €50.87m |
| Earnings | €19.15m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Oct 26, 2023
| Earnings per share (EPS) | 0.72 |
| Gross Margin | 71.43% |
| Net Profit Margin | 19.54% |
| Debt/Equity Ratio | 19.4% |
How did R0V perform over the long term?
See historical performance and comparison